Goodwill and Intangible Assets (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Mar. 29, 2024 |
Mar. 31, 2023 |
Mar. 29, 2024 |
Mar. 31, 2023 |
|
| Goodwill and Intangible Assets Disclosure [Abstract] | ||||
| Goodwill, period increase (decrease) | $ 0.0 | $ 0.0 | ||
| Goodwill, impairment loss | 0.0 | 0.0 | ||
| Completed and transferred in-process research and development | $ 55.7 | $ 1.8 | $ 55.7 | $ 9.5 |
| Finite-lived intangible assets, useful life | 8 years | 12 years | 8 years | 12 years |
| Amortization of intangible assets | $ 45.5 | $ 51.4 | $ 93.6 | $ 123.4 |
| X | ||||||||||
- Definition Completed and transferred in-process research and development No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|